CD274 and neoplasm: Chronic BCG exposure promotes sustained PD-L1 expression on tumor cells and infiltrating myeloid populations, thereby inhibiting cytotoxic T cell activity and creating an immunosuppressive microenvironment that underlies BCG treatment failure (126).